Cathy E. Nolan
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
-
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
- Co-authors
- Sari H. Enschede (7 shared papers)Todd Busman (6 shared papers)Rod Humerickhouse (5 shared papers)Moacyr Oliveira (1 shared paper)Christine L. Hann (1 shared paper)Philip M. Hemken (1 shared paper)Evelyn McKeegan (1 shared paper)Caroline Dive (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (2 papers)Hematological Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesAustraliaEgypt
In The Last Decade
Cathy E. Nolan
8 papers receiving 607 citations
Cathy E. Nolan's Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 111
- Oncology 190
- Pathology and Forensic Medicine 112
- Hematology 63
- Molecular Biology 382
Countries citing papers authored by Cathy E. Nolan
This map shows the geographic impact of Cathy E. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy E. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy E. Nolan more than expected).
Fields of papers citing papers by Cathy E. Nolan
This network shows the impact of papers produced by Cathy E. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy E. Nolan. The network helps show where Cathy E. Nolan may publish in the future.
Co-authors
The 25 scholars most cited alongside Cathy E. Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors Hit paper breakdown → | 2011 | 490 |
| 2 | 2018 | 54 | |
| 3 | 2012 | 28 | |
| 4 | 2013 | 21 | |
| 5 | 2013 | 10 | |
| 6 | 2012 | 7 | |
| 7 | 2017 | 4 | |
| 8 | 2010 | 4 |
About Cathy E. Nolan
Cathy E. Nolan is a scholar working on Genetics, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 8 papers that have together received 618 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers), Lung Cancer Research Studies (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Lung Cancer Treatments and Mutations (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Genetics (111 citations), Oncology (190 citations), Pathology and Forensic Medicine (112 citations), Hematology (63 citations) and Molecular Biology (382 citations). Cathy E. Nolan has collaborated with scholars based in United States, Australia and Egypt. Frequent co-authors include Sari H. Enschede, Todd Busman, Rod Humerickhouse, Moacyr Oliveira, Christine L. Hann, Philip M. Hemken, Evelyn McKeegan, Caroline Dive, Hao Xiong and Leena Gandhi. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.